Full Description
This book provides new insight into advanced medical theories and treatments, such as cavitation ultrasound and unique liposuction methods. It offers several suggestions and insights into the holistic management of the condition intending to serve as a comprehensive reference on lipoedema. One of the book's key goals is to explain how to differentiate other illnesses from Lipoedema when showing symptoms of swollen legs. More than 25% of its population is affected, with women being the primary patients. In addition, many women experience emotional distress due to this disease's effects on the body, mainly including an abnormal buildup of fat in the legs. Doctors often need to be more well-trained to recognize this disease; therefore, it's necessary to highlight it and provide some guidelines and patient assistance.
This book, Lipoedema, expands the knowledge base of medical professionals, biology and medical students, allied health practitioners, and the general public. It bridges the gap between clinical medicine and basic research, laying a strong foundation for future advancements in the treatment of this disease.
Contents
Part I Basic Considerations.- Ch 1 History.- Ch 2 Epidemiology.- Ch 3 Anatomy.- Ch 4 Lymphatic dysfunction.- Ch 5 Fat metabolism and dysfunction in Lipoedema.- Ch 6 Inflammatory processes and cellular mechanisms.- Ch 7 Genetic of Lipoedema.- Ch 8 Veno-lymphatic relationship in Lipoedema.- Ch 9 Classification of Lipoedema.- Part 2 Lipoedema.- Ch 10 Risk factors.- Ch 11 Clinical Manifestation.-Ch 12 Clinical Examination.- Ch 13 Causes.- Ch 14 Diagnosis.- Ch 15 Differential diagnosis.- Ch 16 Histopathology.- Ch 17 Prognosis.- Part 3 Conservative management.- Ch 18 Diet.- Ch 19 Compression stocking.- Ch 20 MLD.- Ch 21 Exercise.- Ch 22 Mental health support.- Ch 23 Shockwave and cavitation ultrasound.- Part 4 Surgical Management.- Ch 24 Lipectomy.- Ch 25 Bariatric surgery.- Ch 26 Liposuction.- Part 5 Holistic management.- Ch 27 Associated cardio-vascular comorbidities.- Ch 28 Associated connective tissue disorder comorbidities.- Ch 29 Associated neurological comorbidities.- Ch 30 Associated mobility comorbidities.- Ch 31 Enhancing healthcare team outcome.- Part 6 Conclusion.- Ch 32 Conclusion.
